Listed

Healthstream Inc

HSTMNasdaqCIK 1095565TechnologyFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$83.7m, Q2 FY2026
Operating income$8.3m, Q2 FY2026
Net income$6.7m, Q2 FY2026
Healthstream Inc, income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m70.3Revenue, Q3 FY2023, three months to 2023-09-30$70.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-10-24, accession 0001437749-24-032036.Report this figure70.6Revenue, Q4 FY2023, three months to 2023-12-31$70.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-27, accession 0001437749-26-005916. Derived: 12-month figure less the 9-month figure.Report this figure72.8Revenue, Q1 FY2024, three months to 2024-03-31$72.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-09, accession 0001437749-25-015812.Report this figure71.6Revenue, Q2 FY2024, three months to 2024-06-30$71.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-07, accession 0001437749-25-025468.Report this figure73.1Revenue, Q3 FY2024, three months to 2024-09-30$73.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001437749-25-033632.Report this figure74.2Revenue, Q4 FY2024, three months to 2024-12-31$74.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-27, accession 0001437749-26-005916. Derived: 12-month figure less the 9-month figure.Report this figure73.5Revenue, Q1 FY2025, three months to 2025-03-31$73.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001437749-26-015213.Report this figure74.4Revenue, Q2 FY2025, three months to 2025-06-30$74.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001437749-26-026301.Report this figure76.5Revenue, Q3 FY2025, three months to 2025-09-30$76.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001437749-25-033632.Report this figure79.7Revenue, Q4 FY2025, three months to 2025-12-31$79.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-27, accession 0001437749-26-005916. Derived: 12-month figure less the 9-month figure.Report this figure81.2Revenue, Q1 FY2026, three months to 2026-03-31$81.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001437749-26-015213.Report this figure83.7Revenue, Q2 FY2026, three months to 2026-06-30$83.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001437749-26-026301.Report this figure
Cost of revenue$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$m10.9Research and development, Q3 FY2023, three months to 2023-09-30$10.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-10-24, accession 0001437749-24-032036.Report this figure11.9Research and development, Q4 FY2023, three months to 2023-12-31$11.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-27, accession 0001437749-26-005916. Derived: 12-month figure less the 9-month figure.Report this figure12.0Research and development, Q1 FY2024, three months to 2024-03-31$12.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-09, accession 0001437749-25-015812.Report this figure12.1Research and development, Q2 FY2024, three months to 2024-06-30$12.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-07, accession 0001437749-25-025468.Report this figure12.1Research and development, Q3 FY2024, three months to 2024-09-30$12.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001437749-25-033632.Report this figure12.7Research and development, Q4 FY2024, three months to 2024-12-31$12.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-27, accession 0001437749-26-005916. Derived: 12-month figure less the 9-month figure.Report this figure12.0Research and development, Q1 FY2025, three months to 2025-03-31$12.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-06, accession 0001437749-26-015213.Report this figure12.1Research and development, Q2 FY2025, three months to 2025-06-30$12.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001437749-26-026301.Report this figure12.1Research and development, Q3 FY2025, three months to 2025-09-30$12.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001437749-25-033632.Report this figure14.8Research and development, Q4 FY2025, three months to 2025-12-31$14.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-27, accession 0001437749-26-005916. Derived: 12-month figure less the 9-month figure.Report this figure13.6Research and development, Q1 FY2026, three months to 2026-03-31$13.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-06, accession 0001437749-26-015213.Report this figure13.6Research and development, Q2 FY2026, three months to 2026-06-30$13.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001437749-26-026301.Report this figure
Operating income$m4.9Operating income, Q3 FY2023, three months to 2023-09-30$4.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-10-24, accession 0001437749-24-032036.Report this figure4.3Operating income, Q4 FY2023, three months to 2023-12-31$4.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-27, accession 0001437749-26-005916. Derived: 12-month figure less the 9-month figure.Report this figure5.7Operating income, Q1 FY2024, three months to 2024-03-31$5.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-09, accession 0001437749-25-015812.Report this figure4.4Operating income, Q2 FY2024, three months to 2024-06-30$4.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-07, accession 0001437749-25-025468.Report this figure6.5Operating income, Q3 FY2024, three months to 2024-09-30$6.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001437749-25-033632.Report this figure4.7Operating income, Q4 FY2024, three months to 2024-12-31$4.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-27, accession 0001437749-26-005916. Derived: 12-month figure less the 9-month figure.Report this figure4.4Operating income, Q1 FY2025, three months to 2025-03-31$4.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001437749-26-015213.Report this figure5.9Operating income, Q2 FY2025, three months to 2025-06-30$5.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001437749-26-026301.Report this figure7.6Operating income, Q3 FY2025, three months to 2025-09-30$7.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001437749-25-033632.Report this figure2.4Operating income, Q4 FY2025, three months to 2025-12-31$2.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-27, accession 0001437749-26-005916. Derived: 12-month figure less the 9-month figure.Report this figure7.5Operating income, Q1 FY2026, three months to 2026-03-31$7.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001437749-26-015213.Report this figure8.3Operating income, Q2 FY2026, three months to 2026-06-30$8.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001437749-26-026301.Report this figure
Income tax$m1.6Income tax, Q3 FY2023, three months to 2023-09-30$1.6m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-10-24, accession 0001437749-24-032036.Report this figure0.8Income tax, Q4 FY2023, three months to 2023-12-31$827.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-27, accession 0001437749-26-005916. Derived: 12-month figure less the 9-month figure.Report this figure1.3Income tax, Q1 FY2024, three months to 2024-03-31$1.3m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-09, accession 0001437749-25-015812.Report this figure1.1Income tax, Q2 FY2024, three months to 2024-06-30$1.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-07, accession 0001437749-25-025468.Report this figure1.8Income tax, Q3 FY2024, three months to 2024-09-30$1.8m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0001437749-25-033632.Report this figure0.6Income tax, Q4 FY2024, three months to 2024-12-31$594.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-27, accession 0001437749-26-005916. Derived: 12-month figure less the 9-month figure.Report this figure0.9Income tax, Q1 FY2025, three months to 2025-03-31$916.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-06, accession 0001437749-26-015213.Report this figure1.5Income tax, Q2 FY2025, three months to 2025-06-30$1.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001437749-26-026301.Report this figure2.2Income tax, Q3 FY2025, three months to 2025-09-30$2.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0001437749-25-033632.Report this figure0.3Income tax, Q4 FY2025, three months to 2025-12-31$317.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-27, accession 0001437749-26-005916. Derived: 12-month figure less the 9-month figure.Report this figure1.9Income tax, Q1 FY2026, three months to 2026-03-31$1.9m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-06, accession 0001437749-26-015213.Report this figure2.0Income tax, Q2 FY2026, three months to 2026-06-30$2.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001437749-26-026301.Report this figure
Net income$m3.9Net income, Q3 FY2023, three months to 2023-09-30$3.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-10-24, accession 0001437749-24-032036.Report this figure4.6Net income, Q4 FY2023, three months to 2023-12-31$4.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-27, accession 0001437749-26-005916. Derived: 12-month figure less the 9-month figure.Report this figure5.2Net income, Q1 FY2024, three months to 2024-03-31$5.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001437749-25-033632.Report this figure4.2Net income, Q2 FY2024, three months to 2024-06-30$4.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001437749-25-033632.Report this figure5.7Net income, Q3 FY2024, three months to 2024-09-30$5.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001437749-25-033632.Report this figure4.9Net income, Q4 FY2024, three months to 2024-12-31$4.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-27, accession 0001437749-26-005916. Derived: 12-month figure less the 9-month figure.Report this figure4.3Net income, Q1 FY2025, three months to 2025-03-31$4.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001437749-26-026301.Report this figure5.4Net income, Q2 FY2025, three months to 2025-06-30$5.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001437749-26-026301.Report this figure6.1Net income, Q3 FY2025, three months to 2025-09-30$6.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001437749-25-033632.Report this figure2.5Net income, Q4 FY2025, three months to 2025-12-31$2.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-27, accession 0001437749-26-005916. Derived: 12-month figure less the 9-month figure.Report this figure5.9Net income, Q1 FY2026, three months to 2026-03-31$5.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001437749-26-026301.Report this figure6.7Net income, Q2 FY2026, three months to 2026-06-30$6.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001437749-26-026301.Report this figure
Diluted EPS$ per share0.13Diluted EPS, Q3 FY2023, three months to 2023-09-30$0.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-10-24, accession 0001437749-24-032036.Report this figurenot reported0.17Diluted EPS, Q1 FY2024, three months to 2024-03-31$0.17 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-09, accession 0001437749-25-015812.Report this figure0.14Diluted EPS, Q2 FY2024, three months to 2024-06-30$0.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-07, accession 0001437749-25-025468.Report this figure0.19Diluted EPS, Q3 FY2024, three months to 2024-09-30$0.19 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001437749-25-033632.Report this figurenot reported0.14Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001437749-26-015213.Report this figure0.18Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.18 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001437749-26-026301.Report this figure0.20Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.20 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001437749-25-033632.Report this figurenot reported0.20Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.20 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001437749-26-015213.Report this figure0.23Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.23 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001437749-26-026301.Report this figure
Basic EPS$ per share0.13Basic EPS, Q3 FY2023, three months to 2023-09-30$0.13 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-10-24, accession 0001437749-24-032036.Report this figurenot reported0.17Basic EPS, Q1 FY2024, three months to 2024-03-31$0.17 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-09, accession 0001437749-25-015812.Report this figure0.14Basic EPS, Q2 FY2024, three months to 2024-06-30$0.14 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-07, accession 0001437749-25-025468.Report this figure0.19Basic EPS, Q3 FY2024, three months to 2024-09-30$0.19 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001437749-25-033632.Report this figurenot reported0.14Basic EPS, Q1 FY2025, three months to 2025-03-31$0.14 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-06, accession 0001437749-26-015213.Report this figure0.18Basic EPS, Q2 FY2025, three months to 2025-06-30$0.18 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001437749-26-026301.Report this figure0.20Basic EPS, Q3 FY2025, three months to 2025-09-30$0.20 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001437749-25-033632.Report this figurenot reported0.20Basic EPS, Q1 FY2026, three months to 2026-03-31$0.20 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-06, accession 0001437749-26-015213.Report this figure0.23Basic EPS, Q2 FY2026, three months to 2026-06-30$0.23 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001437749-26-026301.Report this figure

Balance sheet

Cash and equivalents$46.2m, Q2 FY2026
Shareholders' equity$356.6m, Q2 FY2026
Healthstream Inc, balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m44.1Cash and equivalents, Q3 FY2023, at 2023-09-30$44.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-10-26, accession 0001437749-23-029097.Report this figure40.3Cash and equivalents, FY2023, at 2023-12-31$40.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-02-28, accession 0001437749-25-005705.Report this figure52.4Cash and equivalents, Q1 FY2024, at 2024-03-31$52.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-04-25, accession 0001437749-24-013221.Report this figure46.1Cash and equivalents, Q2 FY2024, at 2024-06-30$46.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-07-25, accession 0001437749-24-023484.Report this figure57.5Cash and equivalents, Q3 FY2024, at 2024-09-30$57.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-10-24, accession 0001437749-24-032036.Report this figure59.5Cash and equivalents, FY2024, at 2024-12-31$59.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-27, accession 0001437749-26-005916.Report this figure77.3Cash and equivalents, Q1 FY2025, at 2025-03-31$77.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-09, accession 0001437749-25-015812.Report this figure52.1Cash and equivalents, Q2 FY2025, at 2025-06-30$52.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-07, accession 0001437749-25-025468.Report this figure53.5Cash and equivalents, Q3 FY2025, at 2025-09-30$53.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001437749-25-033632.Report this figure36.2Cash and equivalents, FY2025, at 2025-12-31$36.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001437749-26-026301.Report this figure48.7Cash and equivalents, Q1 FY2026, at 2026-03-31$48.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-06, accession 0001437749-26-015213.Report this figure46.2Cash and equivalents, Q2 FY2026, at 2026-06-30$46.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001437749-26-026301.Report this figure
Current assets$m127Current assets, Q3 FY2023, at 2023-09-30$126.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-10-26, accession 0001437749-23-029097.Report this figure130Current assets, FY2023, at 2023-12-31$130.2m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-28, accession 0001437749-25-005705.Report this figure147Current assets, Q1 FY2024, at 2024-03-31$147.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-04-25, accession 0001437749-24-013221.Report this figure139Current assets, Q2 FY2024, at 2024-06-30$139.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-07-25, accession 0001437749-24-023484.Report this figure146Current assets, Q3 FY2024, at 2024-09-30$145.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-10-24, accession 0001437749-24-032036.Report this figure153Current assets, FY2024, at 2024-12-31$153.1m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-27, accession 0001437749-26-005916.Report this figure170Current assets, Q1 FY2025, at 2025-03-31$169.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-09, accession 0001437749-25-015812.Report this figure144Current assets, Q2 FY2025, at 2025-06-30$144.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-07, accession 0001437749-25-025468.Report this figure148Current assets, Q3 FY2025, at 2025-09-30$147.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-06, accession 0001437749-25-033632.Report this figure120Current assets, FY2025, at 2025-12-31$119.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001437749-26-026301.Report this figure133Current assets, Q1 FY2026, at 2026-03-31$133.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-06, accession 0001437749-26-015213.Report this figure130Current assets, Q2 FY2026, at 2026-06-30$130.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001437749-26-026301.Report this figure
Total assets$m498Total assets, Q3 FY2023, at 2023-09-30$498.1m. XBRL concept us-gaap:Assets. 10-Q filed 2023-10-26, accession 0001437749-23-029097.Report this figure500Total assets, FY2023, at 2023-12-31$499.9m. XBRL concept us-gaap:Assets. 10-K filed 2025-02-28, accession 0001437749-25-005705.Report this figure512Total assets, Q1 FY2024, at 2024-03-31$511.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-04-25, accession 0001437749-24-013221.Report this figure500Total assets, Q2 FY2024, at 2024-06-30$499.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-07-25, accession 0001437749-24-023484.Report this figure503Total assets, Q3 FY2024, at 2024-09-30$502.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-10-24, accession 0001437749-24-032036.Report this figure511Total assets, FY2024, at 2024-12-31$510.8m. XBRL concept us-gaap:Assets. 10-K filed 2026-02-27, accession 0001437749-26-005916.Report this figure524Total assets, Q1 FY2025, at 2025-03-31$524.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-09, accession 0001437749-25-015812.Report this figure500Total assets, Q2 FY2025, at 2025-06-30$500.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-07, accession 0001437749-25-025468.Report this figure500Total assets, Q3 FY2025, at 2025-09-30$499.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-06, accession 0001437749-25-033632.Report this figure520Total assets, FY2025, at 2025-12-31$520.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001437749-26-026301.Report this figure527Total assets, Q1 FY2026, at 2026-03-31$527.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-06, accession 0001437749-26-015213.Report this figure522Total assets, Q2 FY2026, at 2026-06-30$521.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001437749-26-026301.Report this figure
Current liabilities$m115Current liabilities, Q3 FY2023, at 2023-09-30$114.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-10-26, accession 0001437749-23-029097.Report this figure118Current liabilities, FY2023, at 2023-12-31$118.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-28, accession 0001437749-25-005705.Report this figure126Current liabilities, Q1 FY2024, at 2024-03-31$126.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-04-25, accession 0001437749-24-013221.Report this figure112Current liabilities, Q2 FY2024, at 2024-06-30$111.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-07-25, accession 0001437749-24-023484.Report this figure111Current liabilities, Q3 FY2024, at 2024-09-30$110.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-10-24, accession 0001437749-24-032036.Report this figure116Current liabilities, FY2024, at 2024-12-31$115.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-27, accession 0001437749-26-005916.Report this figure126Current liabilities, Q1 FY2025, at 2025-03-31$125.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-09, accession 0001437749-25-015812.Report this figure115Current liabilities, Q2 FY2025, at 2025-06-30$115.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-07, accession 0001437749-25-025468.Report this figure112Current liabilities, Q3 FY2025, at 2025-09-30$112.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-06, accession 0001437749-25-033632.Report this figure124Current liabilities, FY2025, at 2025-12-31$124.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001437749-26-026301.Report this figure137Current liabilities, Q1 FY2026, at 2026-03-31$136.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-06, accession 0001437749-26-015213.Report this figure123Current liabilities, Q2 FY2026, at 2026-06-30$122.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001437749-26-026301.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m342Shareholders' equity, Q3 FY2023, at 2023-09-30$342.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-10-24, accession 0001437749-24-032036.Report this figure341Shareholders' equity, FY2023, at 2023-12-31$340.8m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-27, accession 0001437749-26-005916.Report this figure345Shareholders' equity, Q1 FY2024, at 2024-03-31$344.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001437749-25-033632.Report this figure349Shareholders' equity, Q2 FY2024, at 2024-06-30$349.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001437749-25-033632.Report this figure355Shareholders' equity, Q3 FY2024, at 2024-09-30$355.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001437749-25-033632.Report this figure359Shareholders' equity, FY2024, at 2024-12-31$359.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001437749-26-026301.Report this figure363Shareholders' equity, Q1 FY2025, at 2025-03-31$362.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001437749-26-026301.Report this figure351Shareholders' equity, Q2 FY2025, at 2025-06-30$350.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001437749-26-026301.Report this figure349Shareholders' equity, Q3 FY2025, at 2025-09-30$349.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001437749-25-033632.Report this figure354Shareholders' equity, FY2025, at 2025-12-31$354.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001437749-26-026301.Report this figure352Shareholders' equity, Q1 FY2026, at 2026-03-31$352.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001437749-26-026301.Report this figure357Shareholders' equity, Q2 FY2026, at 2026-06-30$356.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001437749-26-026301.Report this figure

Cash flow

Operating cash flow$13.4m, Q2 FY2026
Capital expenditure$910.0k, Q2 FY2026
Share repurchases$2.6m, Q2 FY2026
Healthstream Inc, cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m24.7Operating cash flow, Q3 FY2023, three months to 2023-09-30$24.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-10-24, accession 0001437749-24-032036. Derived: 9-month figure less the 6-month figure.Report this figure13.8Operating cash flow, Q4 FY2023, three months to 2023-12-31$13.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-27, accession 0001437749-26-005916. Derived: 12-month figure less the 9-month figure.Report this figure20.9Operating cash flow, Q1 FY2024, three months to 2024-03-31$20.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-09, accession 0001437749-25-015812.Report this figure6.5Operating cash flow, Q2 FY2024, three months to 2024-06-30$6.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-07, accession 0001437749-25-025468. Derived: 6-month figure less the 3-month figure.Report this figure19.1Operating cash flow, Q3 FY2024, three months to 2024-09-30$19.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001437749-25-033632. Derived: 9-month figure less the 6-month figure.Report this figure11.2Operating cash flow, Q4 FY2024, three months to 2024-12-31$11.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-27, accession 0001437749-26-005916. Derived: 12-month figure less the 9-month figure.Report this figure27.1Operating cash flow, Q1 FY2025, three months to 2025-03-31$27.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001437749-26-015213.Report this figure5.0Operating cash flow, Q2 FY2025, three months to 2025-06-30$5.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001437749-26-026301. Derived: 6-month figure less the 3-month figure.Report this figure18.0Operating cash flow, Q3 FY2025, three months to 2025-09-30$18.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001437749-25-033632. Derived: 9-month figure less the 6-month figure.Report this figure13.2Operating cash flow, Q4 FY2025, three months to 2025-12-31$13.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-27, accession 0001437749-26-005916. Derived: 12-month figure less the 9-month figure.Report this figure27.1Operating cash flow, Q1 FY2026, three months to 2026-03-31$27.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001437749-26-015213.Report this figure13.4Operating cash flow, Q2 FY2026, three months to 2026-06-30$13.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001437749-26-026301. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.5Capital expenditure, Q3 FY2023, three months to 2023-09-30$472.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-10-24, accession 0001437749-24-032036. Derived: 9-month figure less the 6-month figure.Report this figure0.3Capital expenditure, Q4 FY2023, three months to 2023-12-31$346.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-27, accession 0001437749-26-005916. Derived: 12-month figure less the 9-month figure.Report this figure0.7Capital expenditure, Q1 FY2024, three months to 2024-03-31$742.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-09, accession 0001437749-25-015812.Report this figure0.2Capital expenditure, Q2 FY2024, three months to 2024-06-30$172.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-07, accession 0001437749-25-025468. Derived: 6-month figure less the 3-month figure.Report this figure0.3Capital expenditure, Q3 FY2024, three months to 2024-09-30$284.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001437749-25-033632. Derived: 9-month figure less the 6-month figure.Report this figure0.2Capital expenditure, Q4 FY2024, three months to 2024-12-31$203.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-27, accession 0001437749-26-005916. Derived: 12-month figure less the 9-month figure.Report this figure1.1Capital expenditure, Q1 FY2025, three months to 2025-03-31$1.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001437749-26-015213.Report this figure2.3Capital expenditure, Q2 FY2025, three months to 2025-06-30$2.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001437749-26-026301. Derived: 6-month figure less the 3-month figure.Report this figure0.1Capital expenditure, Q3 FY2025, three months to 2025-09-30$109.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001437749-25-033632. Derived: 9-month figure less the 6-month figure.Report this figure0.2Capital expenditure, Q4 FY2025, three months to 2025-12-31$204.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-27, accession 0001437749-26-005916. Derived: 12-month figure less the 9-month figure.Report this figure0.7Capital expenditure, Q1 FY2026, three months to 2026-03-31$740.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001437749-26-015213.Report this figure0.9Capital expenditure, Q2 FY2026, three months to 2026-06-30$910.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001437749-26-026301. Derived: 6-month figure less the 3-month figure.Report this figure
Dividends paid$m0.8Dividends paid, Q3 FY2023, three months to 2023-09-30$767.0k. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-Q filed 2024-10-24, accession 0001437749-24-032036. Derived: 9-month figure less the 6-month figure.Report this figure0.8Dividends paid, Q4 FY2023, three months to 2023-12-31$757.0k. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-K filed 2026-02-27, accession 0001437749-26-005916. Derived: 12-month figure less the 9-month figure.Report this figure0.8Dividends paid, Q1 FY2024, three months to 2024-03-31$849.0k. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-Q filed 2025-05-09, accession 0001437749-25-015812.Report this figure0.9Dividends paid, Q2 FY2024, three months to 2024-06-30$851.0k. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-Q filed 2025-08-07, accession 0001437749-25-025468. Derived: 6-month figure less the 3-month figure.Report this figure0.9Dividends paid, Q3 FY2024, three months to 2024-09-30$851.0k. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-Q filed 2025-11-06, accession 0001437749-25-033632. Derived: 9-month figure less the 6-month figure.Report this figure0.9Dividends paid, Q4 FY2024, three months to 2024-12-31$852.0k. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-K filed 2026-02-27, accession 0001437749-26-005916. Derived: 12-month figure less the 9-month figure.Report this figure0.9Dividends paid, Q1 FY2025, three months to 2025-03-31$943.0k. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-Q filed 2026-05-06, accession 0001437749-26-015213.Report this figure0.9Dividends paid, Q2 FY2025, three months to 2025-06-30$947.0k. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-Q filed 2026-08-06, accession 0001437749-26-026301. Derived: 6-month figure less the 3-month figure.Report this figure0.9Dividends paid, Q3 FY2025, three months to 2025-09-30$919.0k. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-Q filed 2025-11-06, accession 0001437749-25-033632. Derived: 9-month figure less the 6-month figure.Report this figure0.9Dividends paid, Q4 FY2025, three months to 2025-12-31$920.0k. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-K filed 2026-02-27, accession 0001437749-26-005916. Derived: 12-month figure less the 9-month figure.Report this figure1.0Dividends paid, Q1 FY2026, three months to 2026-03-31$1.0m. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-Q filed 2026-05-06, accession 0001437749-26-015213.Report this figure1.0Dividends paid, Q2 FY2026, three months to 2026-06-30$1.0m. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-Q filed 2026-08-06, accession 0001437749-26-026301. Derived: 6-month figure less the 3-month figure.Report this figure
Share repurchases$m1.6Share repurchases, Q3 FY2023, three months to 2023-09-30$1.6m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2024-10-24, accession 0001437749-24-032036. Derived: 9-month figure less the 6-month figure.Report this figure7.3Share repurchases, Q4 FY2023, three months to 2023-12-31$7.3m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-27, accession 0001437749-26-005916. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported0.0Share repurchases, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-11-06, accession 0001437749-25-033632. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-27, accession 0001437749-26-005916. Derived: 12-month figure less the 9-month figure.Report this figure0.0Share repurchases, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-05-06, accession 0001437749-26-015213.Report this figure18.1Share repurchases, Q2 FY2025, three months to 2025-06-30$18.1m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-08-06, accession 0001437749-26-026301. Derived: 6-month figure less the 3-month figure.Report this figure6.9Share repurchases, Q3 FY2025, three months to 2025-09-30$6.9m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-11-06, accession 0001437749-25-033632. Derived: 9-month figure less the 6-month figure.Report this figure5.0Share repurchases, Q4 FY2025, three months to 2025-12-31$5.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-27, accession 0001437749-26-005916. Derived: 12-month figure less the 9-month figure.Report this figure6.7Share repurchases, Q1 FY2026, three months to 2026-03-31$6.7m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-05-06, accession 0001437749-26-015213.Report this figure2.6Share repurchases, Q2 FY2026, three months to 2026-06-30$2.6m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-08-06, accession 0001437749-26-026301. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)29.31m, Q2 FY2026
Healthstream Inc, shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares30.7Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3030,662,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-10-26, accession 0001437749-23-029097.Report this figure30.7Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3130,659,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-04-25, accession 0001437749-24-013221.Report this figure30.8Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3030,775,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-07-25, accession 0001437749-24-023484.Report this figure30.8Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3030,769,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-10-24, accession 0001437749-24-032036.Report this figure30.4Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3130,418,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-09, accession 0001437749-25-015812.Report this figure30.5Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3030,526,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-07, accession 0001437749-25-025468.Report this figure30.6Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3030,590,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001437749-25-033632.Report this figure30.6Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3130,587,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-06, accession 0001437749-26-015213.Report this figure30.5Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3030,450,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001437749-26-026301.Report this figure29.8Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3029,811,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001437749-25-033632.Report this figure29.4Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3129,424,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-06, accession 0001437749-26-015213.Report this figure29.3Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3029,314,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001437749-26-026301.Report this figure

Shares outstanding: 29.24mShares outstanding, period not labelled, at 2026-08-0329,239,955 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-06, accession 0001437749-26-026301.Report this figure at Aug 3, 2026, from the cover of the 10-Q filed Aug 6, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:33 ET. Listed shows no prices and gives no investment advice.